Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib for chronic or recurrent antibiotic-refractory pouchitis
NL-OMON23800Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tofacitinib in pouchitis, sponsored by Amsterdam University Medical Center. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
03
Conditions
pouchitis
Beyond the preview
Go deeper on NL-OMON23800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23800.